Ad is loading...
MENU
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xilio Therapeutics (XLO) Ownership - Who owns Xilio Therapeutics?
Profile
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
45.72M
P/E Ratio
N/A
Total Cash
74.95M
Projected Growth
N/A
Total Debt
8.68M
Revenue
2.36M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
1.71
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price
Fundamentals
XLO
Capitalization
45.7M
P/E Ratio
N/A
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
74.9M
Total Cash/Share
1.71
Total Debt
8.68M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.10%
Revenue
2.36M
ROE
N/A
Book Value
33.4M
P/B Ratio
2.18
Cash Flow
N/A
Earnings
-1.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
2.02
Current Revenue Per Employee
32287.67
Dividends Per Share - Security
N/A
EBITDA
-64.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-71.92
Shares Held By Institutions
14.2M
Shares Outstanding - Current
44M
Total Liabilities
56.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
89.091
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com